These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8395510)

  • 1. Ligand-induced accelerated dissociation of (+)-cis-diltiazem from L-type Ca2+ channels is simply explained by competition for individual attachment points.
    Prinz H; Striessnig J
    J Biol Chem; 1993 Sep; 268(25):18580-5. PubMed ID: 8395510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and photoaffinity labeling of receptor sites for the Ca2+ channel inhibitors d-cis-diltiazem, (+/-)-bepridil, desmethoxyverapamil, and (+)-PN 200-110 in skeletal muscle transverse tubule membranes.
    Galizzi JP; Borsotto M; Barhanin J; Fosset M; Lazdunski M
    J Biol Chem; 1986 Jan; 261(3):1393-7. PubMed ID: 3003067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-affinity binding of DTZ323, a novel derivative of diltiazem, to rabbit skeletal muscle L-type Ca++ channels.
    Hagiwara M; Adachi-Akahane S; Nagao T
    J Pharmacol Exp Ther; 1997 Apr; 281(1):173-9. PubMed ID: 9103495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
    Staudinger R; Knaus HG; Glossmann H
    J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric interaction of semotiadil fumarate, a novel benzothiazine, with 1,4-dihydropyridines, phenylalkylamines, and 1,5-benzothiazepines at the Ca(2+)-channel antagonist binding sites in canine skeletal muscle membranes.
    Nakayama K; Nozawa Y; Fukuta Y
    J Cardiovasc Pharmacol; 1994 May; 23(5):731-40. PubMed ID: 7521455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of diltiazem and verapamil on (+)-PN 200-110 binding kinetics in dog cardiac membranes.
    Miwa K; Miyagi Y; Araie E; Sasayama S
    Eur J Pharmacol; 1992 Apr; 214(2-3):127-32. PubMed ID: 1325351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: evidence for interaction at the diltiazem-binding site.
    Felix JP; King VF; Shevell JL; Garcia ML; Kaczorowski GJ; Bick IR; Slaughter RS
    Biochemistry; 1992 Dec; 31(47):11793-800. PubMed ID: 1332772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of diltiazem interaction with L-type Ca2+ channels.
    Kraus RL; Hering S; Grabner M; Ostler D; Striessnig J
    J Biol Chem; 1998 Oct; 273(42):27205-12. PubMed ID: 9765241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma.
    Balwierczak JL; Johnson CL; Schwartz A
    Mol Pharmacol; 1987 Feb; 31(2):175-9. PubMed ID: 2433570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The devapamil-binding site of the purified skeletal muscle receptor for organic-calcium channel blockers is modulated by micromolar and millimolar concentrations of Ca2+.
    Schneider T; Regulla S; Hofmann F
    Eur J Biochem; 1991 Aug; 200(1):245-53. PubMed ID: 1652439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular approach to the calcium channel.
    Glossmann H; Ferry DR; Goll A; Linn T
    Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of four diltiazem stereoisomers on binding of d-cis-[3H]diltiazem and (+)-[3H]PN200-110 to rabbit T-tubule calcium channels.
    Ikeda S; Oka J; Nagao T
    Eur J Pharmacol; 1991 Nov; 208(3):199-205. PubMed ID: 1663043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SR 33557, a novel calcium entry blocker. II. Interactions with 1,4-dihydropyridine, phenylalkylamine and benzothiazepine binding sites in rat heart sarcolemmal membranes.
    Nokin P; Clinet M; Beaufort P; Meysmans L; Laruel R; Chatelain P
    J Pharmacol Exp Ther; 1990 Nov; 255(2):600-7. PubMed ID: 2147036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target size analysis of skeletal muscle Ca2+ channels. Positive allosteric heterotropic regulation by d-cis-diltiazem is associated with apparent channel oligomer dissociation.
    Goll A; Ferry DR; Glossmann H
    FEBS Lett; 1983 Jun; 157(1):63-9. PubMed ID: 6305718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    Wei XY; Rutledge A; Triggle DJ
    Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin binds with high affinity to voltage-dependent L-type Ca2+ channels. Evidence for an agonistic action.
    Knaus HG; Scheffauer F; Romanin C; Schindler HG; Glossmann H
    J Biol Chem; 1990 Jul; 265(19):11156-66. PubMed ID: 2162834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential-dependent allosteric modulation of 1,4-dihydropyridine binding by d-(cis)-diltiazem and (+/-)-verapamil in living cardiac cells.
    Porzig H; Becker C
    Mol Pharmacol; 1988 Aug; 34(2):172-9. PubMed ID: 2457793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain.
    Huber I; Wappl E; Herzog A; Mitterdorfer J; Glossmann H; Langer T; Striessnig J
    Biochem J; 2000 May; 347 Pt 3(Pt 3):829-36. PubMed ID: 10769189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescent probing with felodipine of the dihydropyridine receptor and its interaction with the ryanodine receptor calcium release channel.
    Minarovic I; Mészáros LG
    Biochem Biophys Res Commun; 1998 Mar; 244(2):519-24. PubMed ID: 9514900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective modulation by membrane potential of desmethoxyverapamil binding to calcium channels in rat portal vein.
    Rakotoarisoa L; Sayet I; Mironneau C; Mironneau J
    J Pharmacol Exp Ther; 1990 Dec; 255(3):942-7. PubMed ID: 2175807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.